chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received her second dose of the Moderna covid vaccine on 07/09/2021.  On 07/12/2021 the patient woke up with blurry vision in both eyes.   The patient was seen by an urgent care physician, an optometrist, and a retinal eye specialist.  She was diagnosed with bilateral acute macular neuroretinopathy - post covid.  She was given Durezol 0.05% eye drop four times daily for one week and returned to the specialist on 07/21/2021.  There was no significant improvement in her vision.  The patient will continue the Durezol eye drops for one more week and be seen by the specialist again.
Less than 5 minutes after the vaccination, patient fainted and began vomiting. He was conscious less than a minute after fainting and remained as so until EMS arrived.
Immediately following the shot I had a metallic taste in my mouth that lasted for four days straight. The morning after I had the shot I had tinnitus. The tinnitus has progressively gotten worse over the past couple weeks. I?m not sure if I should get the second vaccine. I do not want us to get worse.
After patient received this vaccine dose, it was discovered that the vial had been stored outside of the recommended temperature range calling into question its efficacy  After conferring with immunization experts it was determined that this dose needs to be repeated.  Patient was contacted by the person completing this form and made aware of this information.  The patient is unsure if she plans to repeat the dose or not.
Pt started having rash on extremities and torso a few days after the flu shot. (It first appeared as a few dots of his arms). Was given BENADRYL.
Information has been received from a physician concerning her son (age not reported) who is allergic to Motrin and has a history of asthma, gastritis, pyloric stenosis and failure to thrive as an infant, who approximately "two years ago" was vaccinated with the first dose of varicella virus vaccine live (Oka/Merck). The physician and mother reported that on approximately 10-JUL-2007 at 15:30, her son was vaccinated in the left upper arm with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck) (lot# not reported) and within 24 hours the child vomited. On approximately 11-JUL-2007 at night the child had fever, 103F, and generalized rash all over the body, especially trunk and upper extremities, small red papules. In addition, the child had a 2 or 3 centimeter red patch at the injection site. It was reported that the child is lethargic and was being treated with Tylenol and hydrocortisone cream on the skin. It was also noted that when the child received the first dose of varicella virus vaccine live (Oka/Merck), he had broken out with vesicles on his leg. The physician and mother reported that her son is extremely allergic to ibuprofen and she thinks the rash is due to hypersensitivity. The patient sought unspecified medical attention. The patient's status was reported as not recovered. Additional information has been requested.
I've been having headaches that can last for days. I usually don't get headaches, but a couple of weeks after getting the vaccine is when it started. So now, every couple of weeks or so I get a headache.
This spontaneous report was received from a licensed practical nurse, and refers to an unspecified numbers of patient of unknown age and gender. On unspecified dates since 01-MAR-2015, the unspecified number of patients were vaccinated with an improperly stored dose of VAQTA lot # K005958; expiration date on 09-FEB-2017 (strength, dose #, dose, route of administration and anatomical location were not provided). There was not concomitant medication reported. No adverse effects were reported. There was not a product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Severe headache/migraine, nausea starting the morning  after the first dose. Treated with Tylenol 500 mg, followed by 400 mg Advil, and Rizatriptan ODT 10 mg, and sleeping. Headache and nausea subsided by 5 pm.  Site of injection also has moderate bruising still present as of date of this report.
Chills; Fever; Swollen; red; Can't walk nor stand; No strength on the legs; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Can't walk nor stand), ASTHENIA (No strength on the legs), CHILLS (Chills), PYREXIA (Fever) and SWELLING (Swollen) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Glaucoma. Concomitant products included SIMVASTATIN, METFORMIN, ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE (PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED;MAGNESIUM CARBONATE]), OMEPRAZOLE, LEVOTHYROXINE SODIUM (SYNTHYROID), BISOPROLOL, BUSPIRONE, DENOSUMAB (PROLIA), VITAMINS NOS and ZINC for an unknown indication, LIPO FLAVONOID PLUS.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced GAIT DISTURBANCE (Can't walk nor stand) and ASTHENIA (No strength on the legs). On an unknown date, the patient experienced CHILLS (Chills), PYREXIA (Fever), SWELLING (Swollen) and ERYTHEMA (red). At the time of the report, GAIT DISTURBANCE (Can't walk nor stand), ASTHENIA (No strength on the legs), CHILLS (Chills), PYREXIA (Fever), SWELLING (Swollen) and ERYTHEMA (red) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not provided by reporter.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Significant worsening of tinnitus. Upon visiting doctor, she reports that I?ve lost some low-end hearing in my left ear as well.
Facial numbness w\drooping. Bells palsy. Predisone/CT scan.  11/14/08 Reviewed PCP medical records of 9/11-11/06/2008. FINAL DX: Bell's palsy Records reveal patient experienced intermittent redness & inflammation of conjunctivae bilaterally.  Right calf also swollen & painful w/equivocal Homan's.  Referred to ophtho & vein center.  RTC 11/1/08 w/numbness/tingling left face w/HA x 2 days.  Tx w/steroids.
Itchiness especially on both arms.  And when I scratch it, red welts are visible and the welts are raised.  You can clearly see the scratch marks.  The itchiness comes and goes but triggers especially at night. Still experiencing the itchiness.  I haven't taken any over the counter allergy medication to relieve the itchiness.
Pt woke up fr nap @ 4PM & screamed & cried x 2 hrs; mom states pt had fever but did not take temp;   pt stiff & could not crawl on bed around 6PM to 630PM; mom stated pt not acting right; mom called MD who advised pt to ER;
Swollen lymph node in left underarm/armpit, fever, chills, body aches (neck and legs), headache
Patient c/o scratchy throat, watery eyes, intermittent tingling sensation on left ear. No itching no rednessnoted, alert and verbal at 10:18am, was given benadryl 25mg.   vitals  9:55am= initial BP 139/90 P- 71bpm, RR-18cpm, 02= 99% RA 10:17am= BP 119/68, P- 78, RR- 18, o2- 99% RA 10:33am= BP 116/81 P- 69, RR-18, o2 99% RA  #21 patient stable and went home
Tested positive for Covid on September 2, 2022.  Went to Urgent Care September 3rd. Received an inhaler.  Went to Emergency Room on September 4th an received antibody infusion.
Five days after receiving the second dose of the vaccine I started to feel a wheezing dull chest pain that seemed like my heartbeat. It subsided and the feeling woke me up from sleep. It felt like a dull chest pain that lasts about two minutes. I went to the ER and it has happened about 6 times and it has been a week since my shot. I was discharged and advised to return if it gets worse. It has happened again, but it does not seem to be getting worse. Due Date-10/09/2021. Pregnancy-first.
After receiving injection i started having mouth ulcers.  On March 4, 2023 I became very sick with headache and nausea.  I was admitted to hospital on March 7th.  Diagnosis was viral herpes complex encephalitis.  Discharged on March 12th
felt flu like symptoms; under the shoulder "not swollen but puffy"; puffy rash on shoulder; itchiness of arm; hives on arm; redness about 5 inches long up and down arm around site of injection; tenderness of injection site; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (felt flu like symptoms), SKIN SWELLING (under the shoulder "not swollen but puffy"), RASH (puffy rash on shoulder), VACCINATION SITE PRURITUS (itchiness of arm) and VACCINATION SITE URTICARIA (hives on arm) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, the patient experienced SKIN SWELLING (under the shoulder "not swollen but puffy"), RASH (puffy rash on shoulder), VACCINATION SITE PRURITUS (itchiness of arm), VACCINATION SITE URTICARIA (hives on arm), VACCINATION SITE ERYTHEMA (redness about 5 inches long up and down arm around site of injection) and VACCINATION SITE PAIN (tenderness of injection site). On 14-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (felt flu like symptoms). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (felt flu like symptoms), SKIN SWELLING (under the shoulder "not swollen but puffy"), RASH (puffy rash on shoulder), VACCINATION SITE PRURITUS (itchiness of arm), VACCINATION SITE URTICARIA (hives on arm), VACCINATION SITE ERYTHEMA (redness about 5 inches long up and down arm around site of injection) and VACCINATION SITE PAIN (tenderness of injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The 2nd dose scheduled on 26-May-2021. Tylenol used as treatment. No concomitant products reported.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Updated patient demographics, no other new information was received.
RSV; Nauseous; Dry heaves caused by mucus; Lost 10 lbs in 15 days; Feel bad all over; No apetite; Malaise, feeling ill; This case was reported by a consumer via interactive digital media and described the occurrence of respiratory syncytial virus infection in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In February 2023, unknown after receiving Shingles vaccine, the patient experienced malaise. On an unknown date, the patient experienced respiratory syncytial virus infection, nausea, dry heaves, weight loss, feeling bad and appetite absent. On an unknown date, the outcome of the respiratory syncytial virus infection, nausea, dry heaves, weight loss, malaise, feeling bad and appetite absent were unknown.   It was unknown if the reporter considered the respiratory syncytial virus infection, nausea, dry heaves, weight loss, malaise, feeling bad and appetite absent to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 24-Feb-2023 Reporter's comments: The case was received from the patient via interactive digital media. The patient did not know if he/she had respiratory syncytial virus infection (RSV) but he/she was nauseous, dry heaves caused by mucus, had lost 10 lbs in 15 days, his/her body had malaise (felt bad all over), no appetite.  The patient need to get some help to determine what he/she had and find a treatment.  The patient started feeling ill after Shingle vaccination, 15 days ago. Additional supportive information: The follow-up could not be possible as no contact details were available. All the reported adverse events were coded as events considering that the patient had experienced all after vaccination.
Pt experienced swelling, redness, warmth and hardening of the thigh; cellulitis. Put on omnicef. Pt treated with antibiotic therapy.
Dizziness; BP 102/69; HR 77; RR 18. Given apple juice.  Final VS BP 113/74; HR 78; RR 18. Pt stable & released from vaccination site
Narrative: PRINCIPAL DIAGNOSIS (Reason for admission after study): Acute hypoxic respiratory failure and Klebsiella pneumonia patient discharged 3-13-22 and reported deceased 3-31-22. HISTORY OF PRESENT ILLNESS: Patient is a 72 yo M with PMH of tonsillar ca s/p 37 radiation treatments/ 3 cycles chemo 2020, depression, TBI secondary to fall with subdural hematoma, recently d/c from facility 02/08/2020 after 5 day stay for inpatient covid pneumonia despite having received both Moderna vaccines in 2021 (no booster). Patient received IV steroids and Remdesivir and was d/c to home on 2 L O2 NC. Patient lives with his wife. He has noticed progressive dyspnea at rest and with exertion for the past 2-3 weeks, as well as intermittent chest tightness (at rest and with exertion), and dizziness with falls. He has a walker, denies any syncope, but notes that he will fatigue easily upon walking short distance and loose balance/fall. Patient also reports cough that can be productive at times with dark yellow sputum. He is afebrile. O2 sats were in the lows 90s on 2 L on admission, increased to 4-5 L with O2 stats of 94 to 95% HOSPITAL COURSE: 1. Acute on chronic hypoxic respiratory failure 2. Previous COVID pneumonia 3. Severe malnutrition 4. Previous head neck cancer 5. Acute diastolic heart failure 6. Chronic BPH 7. Hyperlipidemia 8. Anxiety/PTSD 9. Acute gram-negative bacterial pneumonia, Klebsiella pneumonia Patient continued to improve and on the day of discharge the patient was noted to be satting 96% on the 4 L nasal cannula. Patient has already been approved for home oxygen and was on oxygen prior to coming into the hospital. Patient will be discharged on continued oxygen. Sputum culture was growing Klebsiella pneumonia and the patient was started on cefepime on 3/8/2022. We switched the patient to Rocephin IV which was continued for a total of 5 days on the inpatient setting. Patient will be converted to Keflex to complete a total 14-day course. Prescription was written for this on the day of discharge. Highly suspect this is likely what is contributing to the patient's respiratory failure and worsening clinical status. Patient does appear to have pulmonary hypertension and diastolic heart failure that is likely contributing. Patient's Lasix was increased to twice daily on 3/7/2022 but the patient was getting a little prerenal so decreased this to once a day. Prescription was written for this medication as well. Patient is also having some dysphagia but after talking with the patient, the patient has been having this issue for a number of years. Patient has a history of head neck cancer so I did do a CT scan of the neck on 3/7/2022 that was unremarkable.
Admitted s/p fall down multiple stairs with resulting rib fxs. On admission noted to have multifocal pna and subsequently + COVID-19. Tx w/remdesivir, steroids, O2, zinc;  weaned to 5 L NC. Dc'd to SNF.
given an undiluted dose, so she got 6 times the intended dose.; This is a spontaneous report from a contactable consumer. A 20-years-old female patient (reporter's daughter) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Batch/Lot Number: not reported), via an unspecified route of administration on 01Sep2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Batch/Lot Number: not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. On an unspecified date, the patient was given an undiluted dose, so she got 6 times the intended dose. She weighed 90 pounds, and caller was asking what she needs to be concerned about and look out for. Asked if she needs to take her to the ER (emergency room). The outcome of the event was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
20mins after the shot. I rapidly developed a fever and had trouble seeing. Felt like fainting. Really nauseous stomach and diarrhea. Chills but with a high fever. Threw up 25mins after shot. Immediately after that felt really nauseous and couldn?t see straight. Vision was black and I was seeing stars. Felt like hallucinating really bad. Couldn?t focus my vision. Got home and showered with a really hot shower and immediately started feeling better. 45mins to 1 hour after shot started feeling way better! Just sluggish the rest of the night.  For some reason was fighting going to sleep and fell asleep sitting up. Next day much better!
Uncomfortable in the chest area./ Feels like something is in my chest.; Faster heart rate; Pain in the area; Dizziness/lightheaded; This is a spontaneous report from a contactable consumer (patient). A 39-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6205, Expiry date: unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 05Mar2021 09:45 (at the age of 39 years) as dose 1, single for covid-19 immunisation. Medical history included drug hypersensitivity to Penicillin. Concomitant medications included colecalciferol (VITAMIN D) and Multi Vitamins. Vaccine facility type was at the event centre. No other vaccine received in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has not been tested for COVID-19. The patient experienced uncomfortable in the chest area, faster heart rate, felt like something was in her chest, pain in the area and dizziness/lightheaded on 06Mar2021. The patient received any treatment for the events was unknown. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included heart rate: faster on 06Mar2021. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
Patient became pale and c/o feeling hot at 2100, 5 min after flu vaccine was given.
Vaccine was ordered for Hep A and it was too soon(minimum interval is 6 months) Vaccine not given.
Red circle approx 2 inches in diameter around injection site, not raised, warm to touch, painful when touched, no fever or chills or any other complaints.
I've had a headache and severe joint pain since getting my dose on 4/13. It has not relented and I have not been able to complete daily activities because of it.
This report describes the occurrence of death in child of unspecified age who received hepatitis B vaccine recombinant (Engerix-B) injection.  The report was received as part of litigation proceedings and has not been verified by a physician or other health care professional.  On an unspecified date, the pt received either Engerix-B vaccine (lot number unknown) or Infanrix vaccien (Lot # DTPA958A2 or lot # DTPA524A2). On 12/10/03, the pt's attorney alleged that "the thimerosal contained in the vaccine administered to the children (child) contributed to and/or caused their deaths."  No further information regarding the specifics of their claims is available at this time.  It is unknown whether an autopsy was performed.
Day 1: pain on site of injection, lethargy. Day 2: pain on site of injection, all over muscle pain, fever of 102 F. Day 3: pain on site of injection, all over muscle pain, no more fever.
PATIENT DEVELOPED SEVERE PAIN ON RIGHT ARM AND COULD BARELY LIFT THE ARM. THERE WAS A LITTLE BIT OF REDNESS AROUND THE INJECTION SITE AREA. THESE SYMPTOMS STARTED THE DAY OF VACCINATION AND STARTED TO IMPROVE OVER SEVERAL DAYS. PATIENT FULLY RECOVERED BY 10/1/2019
Blurred vision and dizziness within 10-15 min of injection that lasted several days. Intermittent dizziness and tinnitus continued for several weeks.
A few weeks after the second shot, I developed an intermittent left bundle branch block (LBBB). Initially this block was occurring with elevated heart rate, but at very low (usually below 100bmp, sometimes as low as 70bpm) . I have an Apple Watch ECG which is able to record the arrythmia when I feel it, and reviewing my previously recorded ECG's I had no indication of an LBBB this prior to this time. I subsequently had a full workup including Echocardiogram, Stress Echo, 24hr monitor, blood tests (lyme, covid, calcium etc) as well as a Cardiac MRI. None of those tests have determined any functional issue with my heart, nor any obvious scarring or inflammation. It's not fully clear if this was related to my vaccine other than time of onsite was highly correlated with my second shot. Since the initial issues in May, I have trended towards better, with the LBBB usually now only occurring at very high heart rates ranging from 160-180bpm. It however has not gone away completely and this interferes with my ability to exercise (hike, mountain bike) because I must restrict my exertion to keep below the trigger (which is variable and hard to predict).
functional asplenia; a 68 year-old / 6 years ago received a conjugated vaccine (either Menactra or Menveo); This case was reported by a pharmacist via call center representative and described the occurrence of functional asplenia in a 68-year-old female patient who received Men ACWY-CRM NVS (Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine) for prophylaxis.   On an unknown date, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. On an unknown date, unknown after receiving Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, the patient experienced functional asplenia (serious criteria GSK medically significant) and inappropriate age at vaccine administration. On an unknown date, the outcome of the functional asplenia and inappropriate age at vaccine administration were unknown.   It was unknown if the reporter considered the functional asplenia to be related to Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The 68 year old patient had functional asplenia that 6 years ago received a conjugated vaccine (either Menactra or Menveo), which led to inappropriate age at vaccine administration and there was no records on that shot. The reporter consented to follow up.  No lot or expiration date of product since not received at that location.
Four weeks after receiving the COVID-19 vaccine in the R arm (2nd dose of PFizer), patient came to neurology clinic complaining of R arm tingling sensation in radial nerve distribution that had started two weeks ago (two weeks after getting the vaccine). No weakness or numbness.
Pt recvd Hep B vax & w/in 24 hrs following vax devel a rash on face & chin; rash persisted for several wks;
Child nauseated by the time they got home. Vomited 3 X during the night. Currently running very low grade fever.
Started with sore throat, felt like throat was closing. Started getting feverish feeling and body aches.